Manolis is Deputy Director, Value and Access at IFPMA. His work focuses on procurement, pricing, market access, health technology assessments as well as on coordinating industry engagement on these topics with multilateral stakeholders such as WHO and OECD.

He has 26 years of experience, both in pharma and medical devices. He previously worked at Boehringer Ingelheim, Novo Nordisk, and Medtronic in market access and government affairs roles in multiple therapies and geographies, as well as on trade negotiations. Until recently, he was elected Chair of the Research and Innovation Committee of MedTech Europe, with focus on EU funded projects.

Manolis holds a master’s degree in health studies from the University of Kent in Canterbury, UK. and a B.Sc. in Economics from the National and Kapodistrian University of Athens, Greece. He has also acquired certificates on “The Economic Evaluation of Medical Therapies and Other Health Care Technologies” from the London School of Economics and on “Executive Leadership Skills” from the Wharton University in Philadelphia, USA.